Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,050.00
Bid: 12,038.00
Ask: 12,040.00
Change: -106.00 (-0.87%)
Spread: 2.00 (0.017%)
Open: 12,092.00
High: 12,178.00
Low: 12,010.00
Prev. Close: 12,156.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

BUZZ-U.S. STOCKS ON THE MOVE-Apple, Microsoft, Chipotle, Intuitive Surgical

Wed, 22nd Jul 2015 14:25

(For faster updates on individual market-movers, Eikon usersplease use search string "STXBZ US"; for the Day Aheadnewsletter, http://link.reuters.com/mex49s; for the Morning NewsCall newsletter, http://link.reuters.com/nex49s)U.S. stocks fell in early trading on Wednesday afterdisappointing results from technology giants including Apple,the world's largest publicly traded company. The Dow Jonesindustrial average was down 0.12 percent at 17,897.7, theS&P 500 was down 0.10 percent at 2,116.99 and the NasdaqComposite was down 0.58 percent at 5,177.793.

** APPLE INC, $124.41, -4.85 pct

The company's fourth-quarter revenue forecast fell short ofestimates and it missed some targets for iPhone sales. Theforecast overshadowed Apple's strong sales in China, which morethan doubled to $13.23 billion from a year earlier.

** CHIPOTLE MEXICAN GRILL INC, $724.64, +7.66 pct

The Burrito chain reported a better-than-expected quarterlyprofit as margins rose due to lower ingredient costs. Piper Jaffray, JP Morgan raised price targets.

** INTUITIVE SURGICAL INC, $560.36, +10.94 pct

The robotic surgical equipment maker reported abetter-than-expected quarterly profit and forecast surgicalprocedures to grow 11 to 13 percent this year, sending itsshares up 13 percent.

** BIOGEN, $397.09, -3.03 pct

A 6 mg dose of the drugmaker's experimental Alzheimer'sdisease drug significantly reduced beta amyloid plaque in thebrain but failed to significantly slow mental decline,potentially tempering great enthusiasm that greeted data on twoother doses of the treatment earlier this year.

** XOMA CORP, $1.0788, -75.45 pct

The drug developer says its experimental treatment for aninflammatory disease failed to meet main goal of late-stagestudy. The company says the compound, gevokizumab, was notbetter than a placebo in reducing risk of inflammation inpatients's blood vessels in the eye.

** ABBOTT LABORATORIES INC, $50.9, +2.29 pct

The company reported a slightly better-than-expectedquarterly profit, helped by higher sales of its brandedgenerics.

** LIPOCINE INC, $13.04, +10.60 pct

Analysts at Roth Capital start coverage of the drugmaker'sstock with "buy" rating. We believe Lipocine's LPCN 1021, whichis an oral T formulation, is on track to become the firstlandmark product in the category since the popular Androdermgel's launch in 2000", analysts say.

** MICROSOFT CORP, $46.1801, -2.33 pct

The company reported a $3.2 billion quarterly net loss, itsbiggest ever, as the company wrote down its Nokia phone businessand demand fell for its Windows operating system. The companytook a charge of $7.5 billion in the fourth quarter related tothe restructuring of its Nokia handset business, which it boughtlast year.

** YAHOO INC, $39.07, -1.66 pct

The company forecast lower-than-expected revenue for thecurrent quarter as it struggles to revive its core onlineadvertising business and spends more to attract users to itswebsites.

** REGULUS THERAPEUTICS INC, $9.57, -6.27 pct

Sources cite UBS reoffering 2.33 mln shares versus stock's$10.21 close; expected price and seller(s) not known.

** BOEING CO, $147.92, +2.01 pct

Boeing Co BA.N topped earnings estimates and doubled itsclosely watched quarterly cash flow, partly offsetting a bigcharge for its aerial tanker program.

** THORATEC CORP, $63.07, +9.53 pct

** ST JUDE MEDICAL INC, $77.26, +0.72 pct

Medical device maker St Jude Medical agreed to buy smallerrival Thoratec Corp for about $3.4 billion to expand itsportfolio of heart failure devices.

** AUTONATION, $62.56, -3.34 pct

The largest U.S. auto retailer, reported a 15 percent risein quarterly profit as an improving economy and low oil pricesboosted vehicle sales.

** BHP BILLITON, $38.29, -3.50 pct

** CLIFFS NATURAL RESOURCES INC, $2.56, -12.33 pct

London copper at two-week lows, Chinese steel &iron ore futures fall as demand weakens.

All four of BHP's "four pillars of growth" currently atmulti-year lows and forward price curves charted by Reuterssuggest that is unlikely to change soon. The world's biggestminer has 10 major commodities, including iron ore, copper,petroleum products and coal.

** THERMO FISHER SCIENTIFIC INC, $139.84, +2.47 pct

The world's largest maker of scientific instruments reporteda better-than-expected quarterly profit, helped by lower costsand strength in its life sciences unit.

** INTERPUBLIC GROUP OF COS INC, $20.4, +3.03 pct

The Advertising company's second-quarter revenue trumpedexpectations for the seventh straight quarter as higheradvertising spending by U.S. businesses made up for the strongdollar's impact on international revenue. (Compiled by Rosmi Shaji in Bengaluru; Edited by Don Sebastian)

More News
Today 12:17

CORRECT: Angle shares up on assay development deal with AstraZeneca

(Correcting company name in headline)

Read more
Today 11:50

Angle shares up on assay development deal with AstraZenaca

(Alliance News) - Shares in Angle PLC jumped on Friday, after the company said it has been chosen to develop a prostate cancer assay using its Parsortix technology, opening the door for future clinical study-supporting contracts.

Read more
Today 07:50

LONDON BRIEFING: InterContinental Hotels makes first-quarter progress

(Alliance News) - London's FTSE 100 is called to open higher on Friday, on the expectation of a softer US jobs report, which could take some sting out of hawkish Federal Reserve interest rate expectations.

Read more
2 May 2024 10:04

AstraZeneca notes positive trial results for Calquence treatment

(Alliance News) - AstraZeneca PLC on Thursday said it observed positive high-level results in the Echo phase 3 trial of its Calquence treatment for previously untreated adult patients with mantle cell lymphoma.

Read more
2 May 2024 07:45

AstraZeneca reports positive results from blood cancer drug trial

(Sharecast News) - AstraZeneca has reported positive results from the use of its Calquence drug in a clinical trial to treat a rare type of blood cancer.

Read more
29 Apr 2024 22:52

J&J, Bristol Myers lose challenges to US drug price negotiation program

April 29 (Reuters) - A U.S. judge on Monday rejected a challenge by Bristol Myers Squibb and Johnson & Johnson to a law requiring them to negotiate the prices of their blockbuster blood clot prevention drugs with the U.S government's Medicare health insurance program or pay heavy penalties.

Read more
29 Apr 2024 10:02

LONDON BROKER RATINGS: Deutsche Bank likes Frasers; Barclays cuts JD

(Alliance News) - The following London-listed shares received analyst recommendations Monday morning and Friday:

Read more
29 Apr 2024 09:13

AstraZeneca makes progress with Truqap and Enhertu cancer treatments

(Alliance News) - AstraZeneca PLC on Monday said its Truqap drug has been recommended for approval in the EU to treat a form of breast cancer, while also noting trial results for its Enhertu offering.

Read more
29 Apr 2024 07:50

LONDON BRIEFING: Hipgnosis Songs Fund backs new Blackstone bid

(Alliance News) - London's FTSE 100 is called to open higher on Monday, with heady gains for US tech stocks on Friday brightening the mood in Europe and Asia at the start of the new week.

Read more
29 Apr 2024 07:24

AstraZeneca makes progress with two breast cancer treatments

(Sharecast News) - AstraZeneca issued favourable updates on two of its breast cancer treatments on Monday - 'Truqap', or capivasertib, and 'Enhertu', or trastuzumab deruxtecan - following encouraging results from respective phase three trials.

Read more
26 Apr 2024 09:33

LONDON BROKER RATINGS: Peel Hunt cuts ConvaTec to 'reduce'

(Alliance News) - The following London-listed shares received analyst recommendations Friday morning:

Read more
25 Apr 2024 16:57

LONDON MARKET CLOSE: FTSE 100 shakes off red-hot US inflation gauge

(Alliance News) - London's FTSE 100 outperformed on Thursday, enjoying a solid rise on largely well-received corporate earnings and a share price jump for miner Anglo American after it received a takeover bid from peer BHP.

Read more
25 Apr 2024 15:14

London close: Stocks finish mixed as US GDP growth slows

(Sharecast News) - London's stock markets finished with a mixed performance on Thursday, as investors digested a slower-than-expected GDP growth reading from the United States, while a slew of well-received earnings underpinned the top-flight index.

Read more
25 Apr 2024 11:50

LONDON MARKET MIDDAY: FTSE 100 hits high on offer for Anglo American

(Alliance News) - The FTSE 100 was outperforming European markets at midday on Thursday, with the index boosted to a record high thanks to takeover talks.

Read more
25 Apr 2024 10:33

AstraZeneca leaps after smashing first-quarter forecasts

Q1 revenue up 19% to $12.68 bln

*

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.